SB 1377 revealed the reality of health policy in California

Capitol Weekly welcomes Opinions on California public policy or politics. Please read our guidelines for opinion pieces before submitting an Op-Ed. Submissions that do not adhere to our guidelines will not be considered for publication. 

OPINION – Even a narrowed reform effort exposed how difficult it is to revisit medical exemption policy – and why the conversation must continue

In California, even limited efforts to revisit medical exemption policy face steep resistance. This year’s SB 1377 (Jones) made one thing unmistakably clear: advancing even modest reforms to the state’s medical exemption system is extraordinarily difficult.

The bill’s final committee vote – 3 ayes, 4 noes, and 4 abstentions – only tells part of the story.

The night before the hearing, amendments required by the health committee chair stripped most of the bill’s original substance, which was to repeal previous policy that moved medical exemptions from being granted by one’s doctor to the California Department of Public Health and provide protections for patients from discrimination from healthcare access based on vaccine status.

What remained was a narrow provision on physician exemption thresholds, far from the comprehensive reform initially envisioned. Even then, the bill failed to gain support from Democratic members, underscoring the political headwinds facing any effort to revisit California’s vaccine policy framework.

At the same time, the hearing pointed to a more productive path forward. Committee Chair Sen. Akilah Weber Pierson emphasized that an informational hearing would have been a more appropriate starting point than a rushed bill introduction.

That perspective matters – and it aligns with what Informed Policy Advocates have been urging: a more deliberate, fact-based process.

SB 1377 nonetheless achieved something significant. It brought the issue of medical exemptions back into the legislative process for the first time in years. It secured bipartisan engagement, including Democratic coauthors, and it opened a substantive public conversation about whether the current system is functioning as intended.

That conversation is necessary and timely.

California’s medical exemption rate now sits at roughly 0.1 percent, reflecting how constrained access has become under the current system. This raises a legitimate policy question: does the framework still allow for appropriate individualized medical judgment, or has it become too rigid to account for legitimate medical needs?

At the same time, broader trends are emerging that deserve attention. California is experiencing continued school enrollment declines, following earlier drops after the implementation of SB 277 (Pan) in 2015 and SB 276 (Pan) in 2019.

During the SB 1377 hearing, Sen. Padilla posed a critical question: what is the urgent, exigent, pending public health, community health, issue that this bill seeks to address?

For many school districts, the issue is not abstract. Enrollment declines translate directly into reduced funding, affecting staffing, programs and student services. This year’s 1.3 percent statewide enrollment drop may appear modest, but each percentage point carries real fiscal consequences.

Whether exemption policies are a contributing factor is not yet clear – but it is a question policymakers should be willing to examine. For any and all children who are denied school access because they are unable to obtain their medical exemption, this is an urgent issue that needs to be remedied so that they can have their civil right to be in their classroom of peers.

These outcomes were not the stated intent of prior legislation. When SB 277 was enacted, its authors emphasized that children with legitimate medical needs would retain access to exemptions and that physicians would maintain discretion in making those determinations. A decade later, some stakeholders argue that the system has become more restrictive in practice.

Reports of institutional caution – from hospital policies to physician concerns about regulatory scrutiny – have contributed to a growing perception among some families that the process lacks flexibility. Whether that perception is fully borne out by data is precisely the type of question that warrants further legislative review.

That is why renewed engagement is essential.

Informed Policy Advocates is now working with lawmakers and the California Department of Public Health to support one or more informational hearings.

The objective is not to roll back public health protections, but to ensure the system strikes the appropriate balance – one that safeguards community health while maintaining trust, transparency, and the role of physician judgment.

California has long been a national leader in public health policy. It should also lead in evaluating outcomes and making thoughtful adjustments when warranted.

SB 1377 may not have advanced, but it succeeded in reframing the conversation. It highlighted both the political sensitivity of the issue and the need for a more structured, data-driven approach.

This is not the end of the debate—it is the beginning of a more deliberate path forward.

Darrlene Alquiza is the CEO, executive director and co-founder of Informed Policy Advocates, a California-based advocacy organization focused on informed consent, medical consumer protections and civil rights in healthcare policy.